MiMedx
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $84,057 | $87,207 | $84,709 | $86,832 |
Gross Profit | 68,735 | 72,162 | 71,533 | 72,990 |
EBITDA | 12,192 | 23,450 | 13,999 | 16,308 |
EBIT | 11,419 | 22,683 | 13,252 | 15,505 |
Net Income | 8,095 | 17,625 | 9,261 | 62,688 |
Net Change In Cash | 84,057 | 87,207 | 84,709 | 86,832 |
Free Cash Flow | 23,219 | 21,395 | 3,733 | 9,776 |
Cash | 88,801 | 69,037 | 48,487 | 82,000 |
Basic Shares | 148,373 | 148,897 | 150,028 | 148,076 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $321,477 | $267,841 | $258,615 | $248,234 |
Gross Profit | 266,843 | 219,525 | 215,332 | 208,904 |
EBITDA | 40,517 | -10,685 | -1,891 | -45,764 |
EBIT | 37,090 | -14,731 | -8,063 | -53,602 |
Net Income | 67,439 | -30,197 | -10,285 | -49,284 |
Net Change In Cash | 321,477 | 267,841 | 258,615 | 248,234 |
Cost of Revenue | -8,729 | 26,743 | ||
Free Cash Flow | 24,788 | -20,577 | -5,452 | -41,630 |
Cash | 82,000 | 65,950 | 87,083 | 95,812 |
Basic Shares | 145,962 | 112,909 | 110,353 | 108,257 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.05 |
2024-06-30 | $0.12 |
2024-03-31 | $0.07 |
2023-12-31 | $0.32 |
